ANGELA JUNGE: Open Payments
NPI 1053874586 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 15 payments from 10 companies in 2025. Trend: 2023 $237 · 2024 $379 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $78 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: MOUNJARO, ELIQUIS, SHINGRIX, TZIELD, Quviviq, FREESTYLE LIBRE 3, Natroba, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
